Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Receivables - Net: 2024

Historic Receivables - Net for Madrigal Pharmaceuticals (MDGL) over the last 1 years, with Dec 2024 value amounting to $53.8 million.

  • Madrigal Pharmaceuticals' Receivables - Net rose 271.88% to $113.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $113.3 million, marking a year-over-year increase of 271.88%. This contributed to the annual value of $53.8 million for FY2024, which is N/A change from last year.
  • Madrigal Pharmaceuticals' Receivables - Net amounted to $53.8 million in FY2024.
  • Madrigal Pharmaceuticals' Receivables - Net's 5-year high stood at $53.8 million during FY2024, with a 5-year trough of $53.8 million in FY2024.
  • Moreover, its 1-year median value for Receivables - Net was $53.8 million (2024), whereas its average is $53.8 million.